Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Molecular Resonance Quantification and Label-Free Interactome Characterization of Total Proteome of Tumor Specimens Decipher Responder and Success Predictors in Colorectal Cancer Patients Treated With Panitumumab. | Cancer Med | 2025 | 41319168 | PubTator, text mining | PubMed |
| JMJD1B-mediated FEN1 demethylation allows timely switching of Okazaki fragment maturation core enzymes to avoid mutagenic flap ligation by PARP1-LIG3. | bioRxiv | 2025 | 41280084 | PubTator, text mining | PubMed |
| XPF mediates 3' flap processing for FEN1-independent Okazaki fragment maturation. | bioRxiv | 2025 | 41279254 | PubTator, text mining | PubMed |
| Computational identification and evaluation of novel PD-L1 inhibitors for cancer immunotherapy. | Sci Rep | 2025 | 41028747 | PubTator, text mining | PubMed |
| Exploring the effect of capsaicin on gene expression and chemotherapy sensitization in gastric cancer cells. | Eur J Med Res | 2025 | 41013815 | PubTator, text mining | PubMed |
| Identification of immunosuppressive CD4+ T-cell subtype and construction of prognostic model for hepatocellular carcinoma. | Discov Oncol | 2025 | 40996677 | PubTator, text mining | PubMed |
| Investigation of radiation-induced DNA damage repair-related genes as diagnostic biomarkers for radiation. | J Radiat Res | 2025 | 40992406 | PubTator, text mining | PubMed |
| DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. | World J Gastrointest Oncol | 2025 | 40977667 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of magnolol-sulforaphane hybrid analogues as potential therapeutics of triple-negative breast cancer. | Eur J Med Chem | 2025 | 40961586 | PubTator, text mining | PubMed |
| Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer. | Cancer Sci | 2025 | 40957713 | PubTator, text mining | PubMed |
| Tumor irradiation induced immunogenic response: the impact of DNA damage induction and misrepair. | Radiat Oncol | 2025 | 40841665 | PubTator, text mining | PubMed |
| Proteogenomic characterization of invasive breast tumors in young women. | NPJ Breast Cancer | 2025 | 40826002 | PubTator, text mining | PubMed |
| Single-molecule analysis of gap and nick binding by LIG1 and LIG3α at the final step of DNA repair. | bioRxiv | 2025 | 40666977 | PubTator, text mining | PubMed |
| Identification of FANCG as a prognostic factor for prostate cancer. | Eur J Med Res | 2025 | 40635081 | PubTator, text mining | PubMed |
| Mechanistic Insights into Ligand-Mediated Modulation of 14-3-3η/Parkin Interaction through Molecular Dynamics and Enhanced Sampling Simulations. | J Phys Chem B | 2025 | 40622900 | PubTator, text mining | PubMed |
| Structural and molecular basis of PCNA-activated FAN1 nuclease function in DNA repair. | Nat Commun | 2025 | 40368897 | PubTator, text mining | PubMed |
| A FAN1 point mutation associated with accelerated Huntington's disease progression alters its PCNA-mediated assembly on DNA. | Nat Commun | 2025 | 40368883 | PubTator, text mining | PubMed |
| Joining of DNA breaks- interplay between DNA ligases and poly (ADP-ribose) polymerases. | DNA Repair (Amst) | 2025 | 40347914 | PubTator, text mining | PubMed |
| Nick sealing of polβ mismatch insertion products by LIG1 and LIG3α during 8-oxoG bypass leads to mutagenic or error-free base excision repair. | J Biol Chem | 2025 | 40286853 | PubTator, text mining | PubMed |
| Molecular basis for RNA discrimination by human DNA ligase 1. | Nucleic Acids Res | 2025 | 40239996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=3